|
SNAPIN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.302400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.064400E-01 |
| Normal-vs-Stage2 |
8.074200E-01 |
| Normal-vs-Stage3 |
5.349600E-01 |
| Normal-vs-Stage4 |
9.811400E-01 |
| Stage1-vs-Stage2 |
8.868200E-01 |
| Stage1-vs-Stage3 |
5.538800E-01 |
| Stage1-vs-Stage4 |
9.241600E-01 |
| Stage2-vs-Stage3 |
6.789200E-01 |
| Stage2-vs-Stage4 |
8.604400E-01 |
| Stage3-vs-Stage4 |
6.884200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.882400E-01 |
| Normal-vs-AfricanAmerican |
3.179000E-01 |
| Normal-vs-Asian |
6.818000E-01 |
| Caucasian-vs-AfricanAmerican |
2.530000E-01 |
| Caucasian-vs-Asian |
6.645800E-01 |
| AfricanAmerican-vs-Asian |
3.796800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.177800E-01 |
| Normal-vs-Female |
1.241190E-01 |
| Male-vs-Female |
1.662140E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.789600E-01 |
| Normal-vs-Extreme_Weight |
8.713800E-01 |
| Normal-vs-Obese |
8.993800E-01 |
| Normal-vs-Extreme_Obese |
6.731800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.184200E-01 |
| Normal_Weight-vs-Obese |
4.748200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.201400E-01 |
| Extreme_Weight-vs-Obese |
7.234800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.098200E-01 |
| Obese-vs-Extreme_Obese |
6.356000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.474200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.792000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.045600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.727160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.359000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.362100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.021800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.105900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.900300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.534200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.536400E-01 |
| Normal-VS-Type2 PRCC |
3.780800E-01 |
| Normal-VS-KIRP CIMP |
6.069800E-01 |
| Normal-VS-Unclassified PRCC |
3.775200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.263740E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.030400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.402800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.162000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.891900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.896400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.291000E-01 |
| Normal-vs-N1 |
6.385000E-01 |
| Normal-vs-N2 |
5.081200E-01 |
| N0-vs-N1 |
2.805400E-01 |
| N0-vs-N2 |
3.030400E-01 |
| N1-vs-N2 |
8.545400E-01 |
|
|
